Nature background

Advancing Energy & Healthcare

Developing thorium-based solutions for sustainable energy generation and medical applications.

About Thorium Norway AS

Thorium Norway AS was established in 2015 with the goal of developing new industries to meet the growing demand for the element Thorium (Th 232).

With around 150+ private investors, the company has formed a project group focused on creating a significant industrial venture.

Our mission is to transform thorium-containing mining waste from the Fen area and other sources around the world into valuable products for the nuclear power and pharmaceutical industries.

Latest News and Insights

magnifying scope

Products and Services

Thorium Norway AS, in collaboration with Bilfinger Tebodin Netherlands and Thor Energy AS, has developed a factory concept to produce eight products targeting the nuclear power and pharmaceutical markets.

Our factory is designed to handle approximately 1,200 tons of finished products annually, responsibly managing all low-radioactive materials from the Fen area.

Industry Impact

Our thorium-based research contributes to advancements in nuclear energy technology and medical applications. Through our development work, we aim to improve fuel efficiency and reduce waste in nuclear power generation.

Our focus includes the development of thorium-derived materials for medical applications, particularly in targeted therapies for cancer treatment.

lab worker looking at sample